Emma Kivuva

Oct 25, 2024 | nature.com | Fabiola Ceroni |Munevver B. Cicekdal |Nicolas Chassaing |Thomas Naert |Emma Kivuva |Soeren S Lienkamp | +5 more

AbstractAnophthalmia, microphthalmia and coloboma (AMC) comprise a spectrum of developmental eye disorders, accounting for approximately 20% of childhood visual impairment. While non-coding regulatory sequences are increasingly recognised as contributing to disease burden, characterising their impact on gene function and phenotype remains challenging. Furthermore, little is known of the nature and extent of their contribution to AMC phenotypes.

Jan 16, 2024 | nation.africa | Emma Kivuva

In November last year, the World Health Organisation (WHO) recommended the roll-out of a new malaria vaccine. The vaccine, a product of collaborative research between the University of Oxford and the Serum Institute of India, is the second of its kind endorsed for general population usage. The first vaccine was developed by the pharma giant GlaxoSmithKline (GSK) and funded in part by the Bill and Melinda Gates Foundation.

Nov 21, 2023 | nation.africa | Emma Kivuva

Every year, non-communicable diseases (NCDs) kill 41 million people, about 75 per cent of all mortalities, says the WHO. And at least one person under 70 dies every two seconds due to NCDs or their complications with 86 per cent of these premature fatalities in low- and middle-income countries (LMICs). Incredibly, most of these deaths could be avoided or delayed if people had access to proper prevention, treatment and care services.